Patricia Combes Selected Research

Therapeutics

10/2015

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Combes Research Topics

Disease

3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2013
1	Residual Neoplasm 01/2021
1	Neoplasms (Cancer) 09/2017
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Ichthyosis (Xeroderma) 01/2012
1	Intellectual Disability (Idiocy) 01/2012
1	Muscle Spasticity (Spastic) 01/2012
1	Quadriplegia (Spastic Quadriplegia) 01/2012
1	Sjogren-Larsson Syndrome 01/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2006
1	Juvenile Amyotrophic Lateral Sclerosis 2 06/2006
1	Pelizaeus-Merzbacher Disease 03/2006
1	Hereditary Spastic Paraplegia 03/2006
1	Leukoencephalopathies 07/2004
1	Vanishing White Matter Leukodystrophy with Ovarian Failure 07/2004
1	Ataxia (Dyssynergia) 07/2004

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 08/2006 - 03/2006
2	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 08/2006 - 07/2004
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2017
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	long-chain-aldehyde dehydrogenaseIBA 01/2012
1	GuanosineIBA 06/2006
1	GuanineIBA 06/2006
1	Tyrosine (L-Tyrosine)FDA Link 06/2006
1	Cysteine (L-Cysteine)FDA Link 06/2006
1	Complementary DNA (cDNA)IBA 06/2006
1	ChromatinIBA 06/2006
1	Mutant Proteins (Protein, Mutant)IBA 06/2006
1	Peptide Initiation Factors (Initiation Factor)IBA 07/2004

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 01/2021
1	Adjuvant Chemotherapy 10/2016
1	Therapeutics 10/2015
1	Ligation 01/2013